$NCSM

MORRISON MICHAEL L sold (to issuer) 11,049 shares of NCSM

MORRISON MICHAEL L (See Remarks) sold (to issuer) 11,049 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · MORRISON MICHAEL L
Published Sep 1, 2026, 1:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMBearishLow
01

Why it matters

Insider sales can influence short‑term sentiment, especially when the insider holds a key position.

02

Market read

A routine insider sale with modest size; limited trading relevance.

03

What to watch

The officer may have needed cash for personal reasons; the company’s fundamentals remain unchanged.

Relevance 4/10Novelty 4/10Timing: same day filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

Officer Michael Morrison sold 11,049 shares of NCS Multistage Holdings, reducing his stake to zero.

Expected impact

Potential modest downside pressure in the short term.

Evidence & confidence

Small insider sale by an officer, but the amount is modest relative to market cap; impact likely limited.

Market effects

Minimal effect on the broader biotech sector.

No notable regional impact.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity move, not a bearish signal.

Key entities

  • NCS Multistage Holdings, Inc.

    Biotech firm listed on NASDAQ under ticker NCSM.

  • Michael Morrison

    Officer of NCSM who sold his entire shareholding.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).